Beta Data
-
Carter Griffin explains why the best SaaS companies are obsessed with churn
Fundraising is a numbers game, and many SaaS founders are hoping their financial metrics will show signs of investment potential. But sometimes the founders ... -
Editas Medicine presents preclinical data supporting the
Preclinical data demonstrated robust induction of fetal hemoglobin (HbF) in erythroid progeny cells without detection of off-target editing; cells showed reduced sickling and improved ... -
As AMC shares skyrocketed, an Invesco ‘reopening’ fund sold shares of the meme because that’s how the smart beta ETF works
Hello again: If the actions even have put you to the test, we can’t blame you, given the ongoing turmoil in trading at AMC ... -
“Alzheimer’s disease is open for business:” Controversial FDA approval could pave way for future drugs – TechCrunch
On Monday, a 17-year drought in the Alzheimer’s drug world ended with the FDA approval of Biogen’s Aduhlem (aducanumab). The controversy behind the FDA’s ... -
‘Landmark’ trial to test COVID-19 mRNA vaccines in Africa cannot get coveted vaccines | Science
A new clinical trial hopes to test messenger RNA vaccines for COVID-19 in pregnant women, like this one receiving an ultrasound at an AIDS ... -
Lisinopril may prevent cardiotoxicity from the use of anthracyclines and trastuzumab in breast cancer
Source / Disclosures Published by: Source: Munster PN, et al. Abstract 509. Presented to: ASCO Annual Meeting (virtual meeting); June 4-8, 2021. Disclosures: Munster ... -
Riveting Machines Key Market Trends and Areas of Opportunity | Arconic, Beta Utensili, BÖLLHOFF, DEGOMETAL, DUBUIS Tools, etc – Market research reports
(MENAFN – Market Research Reports) Key Trends and Opportunities of the Riveting Machine Market | Arconic, Beta Utensili, BÖLLHOFF, DEGOMETAL, DUBUIS Tools, etc. By ... -
Intrinsic calculation for Danaher Corporation (NYSE: DHR) suggests it’s 26% undervalued
Today we are going to review a valuation method used to estimate the attractiveness of Danaher Corporation (NYSE: DHR) as an investment opportunity by ... -
GC Cheat Sheet: Hottest Business News of the Week
Law360 (June 4, 2021, 4:19 p.m. EDT) – Lawyers say the most important takeaway from the US Supreme Court’s restriction of the Computer Fraud ... -
PRX-102 at least as effective as Fabrazyme, Interim Data Show
One year of treatment with PRX-102 (pegunigalsidase alfa), an investigational enzyme replacement therapy (ERT), was at least as effective as Fabrazyme (agalsidase beta) in ...
